| 10/15/25 16:05 | 10/14/25 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Reynolds Cameron John | NV | DO | P,CEO | P.d | 56 | 0.5100 | 0 | 110 | 3 | 3,577 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/15/25 16:05 | 10/14/25 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | NV | D |  | P.d | 49 | 0.5100 | 0 | 96 | 3 | 3,437 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/15/25 16:05 | 10/14/25 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Still Timothy I | NV | D |  | P.d | 25 | 0.5100 | 0 | 48 | 3 | 1,535 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 9/19/25 17:26 | 9/17/25 | AWHL | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Schuler Jack W |  | T |  | P.d | 500 | 0.4500 | 0 | 1,111 | 41 | 3,830 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 9/19/25 17:26 | 9/17/25 | AWHL | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cohen Jeffrey K |  | D |  | P.d | 25 | 0.4500 | 0 | 56 | 15 | 437 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 9/19/25 16:05 | 9/17/25 | AWHL | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Fraser John D | PA | D |  | P.d | 7 | 0.4500 | 0 | 16 | 2 | 858 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 9/15/25 09:00 | 9/12/25 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Reynolds Cameron John | NV | DO | P,CEO | P | 10 | 0.6590 | 0 | 15 | 0 | 3,667 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 8/22/25 16:30 | 8/20/25 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Chase William J | MA | D |  | P | 1,003 | 10.03 | 0 | 100 | 288 | 135 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 8/6/25 09:00 | 8/5/25 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | NV | D |  | P | 50 | 0.6400 | 0 | 78 | 2 | 3,341 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 8/6/25 09:00 | 8/5/25 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Reynolds Cameron John | NV | DO | P,CEO | P | 50 | 0.6400 | 0 | 78 | 2 | 3,652 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 6/16/25 08:27 | 6/12/25 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Reynolds Cameron John | NV | DO | P,CEO | P | 7 | 0.5898 | 0 | 13 | 0 | 3,374 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 6/12/25 17:09 | 6/12/25 | ICCC | Immucell Corp /De/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Gathagan Bryan K. | ME | D |  | P | 6 | 6.32 | 0 | 1 | New | 1 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 6/4/25 07:55 | 6/3/25 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | NV | D |  | P | 11 | 0.5386 | 0 | 20 | 1 | 3,263 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 5/19/25 13:23 | 5/19/25 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Micallef Jacob Vincent | NV | O | Chief Sc | P | 22 | 0.4300 | 0 | 50 | 11 | 519 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 5/19/25 12:43 | 5/19/25 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Reynolds Cameron John | NV | DO | P,CEO | P | 9 | 0.4365 | 0 | 20 | 1 | 3,361 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 5/12/25 14:30 | 5/12/25 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Gupta Aashima | MI | D |  | P | 100 | 6.25 | 0 | 16 | 270 | 22 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 4/25/25 16:32 | 4/25/25 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Woteki Catherine E | MI | D |  | P | 30 | 5.17 | 0 | 6 | 77 | 13 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 4/25/25 14:45 | 4/24/25 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Borel James C | MI | D |  | P | 150 | 4.99 | 0 | 30 | 50 | 90 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 4/24/25 15:34 | 4/24/25 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Boehm William T | MI | D |  | P | 26 | 5.24 | 0 | 5 | 16 | 36 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 4/24/25 11:18 | 4/24/25 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Borel James C | MI | D |  | P | 171 | 4.89 | 0 | 35 | 137 | 60 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 4/23/25 10:46 | 4/23/25 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Rocklin Amy M | MI | O | GC | P | 62 | 4.99 | 0 | 13 | 53 | 36 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 4/22/25 15:37 | 4/22/25 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Capello Jeffrey D | MI | D |  | P | 100 | 4.84 | 0 | 21 | 350 | 27 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 4/22/25 11:46 | 4/22/25 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Tobin James P | MI | D |  | P | 47 | 4.73 | 0 | 10 | 36 | 37 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 4/22/25 11:43 | 4/22/25 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Rodriguez Rafael A | MI | D |  | P | 34 | 4.59 | 0 | 7 | 100 | 15 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 4/10/25 10:12 | 4/10/25 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Moylan John Patrick | MI | O | Chief Ac | P | 51 | 5.07 | 0 | 10 | New | 10 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 3/27/25 08:13 | 3/26/25 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Reynolds Cameron John | NV | DO | P,CEO | P | 100 | 0.5500 | 0 | 182 | 6 | 3,341 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 3/27/25 08:13 | 3/26/25 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | NV | D |  | P | 100 | 0.5500 | 0 | 182 | 6 | 3,243 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 3/19/25 16:38 | 3/17/25 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Oki Mark K | WA | O | CFO | P | 29 | 2.89 | 0 | 10 | New | 10 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 3/19/25 16:32 | 3/17/25 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Stewart Richard Alistair | WA | DO | Chieve E | P | 29 | 2.86 | 0 | 10 | 19 | 62 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 2/11/25 19:00 | 2/7/25 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | James Andrea S. | CA | O | CFO | P | 200 | 2.05 | 0 | 98 | 182 | 151 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 2/11/25 17:00 | 2/7/25 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Smith Patrick W | CA | T |  | P | 2,209 | 2.05 | 0 | 1,078 | 49 | 3,258 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 2/10/25 20:43 | 2/6/25 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Broadwood Partners, L.P. | NY | T |  | P.d | 10,590 | 2.05 | 0 | 5,166 | 29 | 22,820 | M |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 2/4/25 16:45 | 1/31/25 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Smith Patrick W | CA | T |  | P.m | 2 | 2.01 | 0 | 1 | 0 | 1,795 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 1/31/25 17:00 | 1/29/25 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Smith Patrick W | CA | T |  | P.m | 8 | 2.01 | 0 | 4 | 0 | 1,794 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 1/16/25 15:28 | 1/16/25 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Naemura David H. | MI | O | CFO | P | 164 | 11.11 | 0 | 15 | 32 | 61 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 1/16/25 12:05 | 1/16/25 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | MI | O | CEO | P | 254 | 11.03 | 0 | 23 | 9 | 269 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 1/15/25 17:00 | 1/13/25 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Smith Patrick W | CA | T |  | P.m | 34 | 2.12 | 0 | 16 | 1 | 1,790 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 12/27/24 21:49 | 12/26/24 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Smith Patrick W | CA | T |  | P | 192 | 2.13 | 0 | 90 | 5 | 1,774 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 12/26/24 18:17 | 12/26/24 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Arno Andrew | CA | D |  | P | 26 | 2.11 | 0 | 13 | 15 | 97 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 12/13/24 16:12 | 12/11/24 | QDEL | Quidelortho Corp |  | Health | Diagn | In Vitro & In Vivo Diagnostic | Blaser Brian J. | CA | O | P,CEO | P | 250 | 41.42 | 0 | 6 | New | 6 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 12/10/24 16:01 | 12/9/24 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | NV | D |  | P | 100 | 0.5722 | 0 | 175 | 6 | 2,991 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 12/10/24 16:01 | 12/9/24 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Still Timothy I | NV | D |  | P | 50 | 0.5722 | 0 | 87 | 6 | 1,487 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 12/10/24 16:01 | 12/9/24 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Micallef Jacob Vincent | NV | O | Chief Sc | P | 25 | 0.5722 | 0 | 44 | 10 | 487 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 12/10/24 16:01 | 12/9/24 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Reynolds Cameron John | NV | DO | P,CEO | P | 80 | 0.5722 | 0 | 140 | 5 | 3,159 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 12/9/24 08:00 | 12/5/24 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | James Andrea S. | CA | O | CFO | P | 46 | 2.29 | 0 | 20 | 59 | 54 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 11/12/24 08:01 | 11/11/24 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Marucci Anthony S | NJ | DO | P,CEO | P | 308 | 26.82 | 0 | 12 | 40 | 40 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/15/24 09:21 | 10/11/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | MI | O | CEO | P | 200 | 13.80 | 0 | 15 | 7 | 216 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/9/24 13:18 | 9/6/24 | CDIO | Cardio Diagnostics Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dogan Timur | IL | O | CTO | P.a | 20 | 0.2900 | 0 | 69 | 54 | 197 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/8/24 10:42 | 9/6/24 | CDIO | Cardio Diagnostics Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dogan Meeshanthini | IL | DO | CEO | P.a | 20 | 0.2900 | 0 | 69 | 4 | 1,655 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/7/24 11:29 | 9/6/24 | NUTX | Cardio Diagnostics Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dogan Meeshanthini | IL | DO | CEO | P.a | 20 | 0.2900 | 0 | 69 | 4 | 1,655 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/4/24 19:40 | 10/2/24 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | James Andrea S. | CA | O | CFO | P | 100 | 2.97 | 0 | 34 | New | 34 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/4/24 19:00 | 10/2/24 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Broadwood Partners, L.P. | NY | T |  | P.d | 3,878 | 2.95 | 0 | 1,315 | 12 | 12,489 | M |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 9/23/24 16:24 | 9/6/24 | NUTX | Cardio Diagnostics Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dogan Timur | IL | O | CTO | P.a | 20 | 0.2900 | 0 | 69 | 54 | 197 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 9/10/24 17:22 | 9/6/24 | CDIO | Cardio Diagnostics Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Philibert Robert | IL | DO | Chief Me | P | 10 | 0.2865 | 0 | 34 | 2 | 1,684 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 9/9/24 11:08 | 9/6/24 | CDIO | Cardio Diagnostics Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dogan Meeshanthini | IL | O | CTO | P | 20 | 0.2900 | 0 | 69 | 54 | 197 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 9/9/24 11:01 | 9/6/24 | CDIO | Cardio Diagnostics Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dogan Meeshanthini | IL | DO | CEO | P | 20 | 0.2900 | 0 | 69 | 4 | 1,684 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 8/21/24 08:26 | 8/20/24 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | NV | D |  | P | 101 | 0.6700 | 0 | 150 | 6 | 2,781 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 8/7/24 10:17 | 8/6/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Tobin James P | MI | D |  | P | 51 | 16.86 | 0 | 3 | 15 | 23 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 7/16/24 21:13 | 7/12/24 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Telegraph Hill Partners Iv, L.P. | CA | T |  | P | 15,000 | 1.24 | 0 | 12,097 | 83 | 26,591 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 7/16/24 17:15 | 7/12/24 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lowell Matthew | CA | O | CFO | P | 50 | 1.24 | 0 | 40 | 46 | 128 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 7/16/24 17:15 | 7/12/24 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Gunstream Stephen | CA | DO | P,CEO | P | 100 | 1.24 | 0 | 81 | 50 | 243 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 7/11/24 17:15 | 7/9/24 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Schuler Jack W | IL | T |  | P.d | 0 | 0.00 | 0 | 7 | 0 | 1,919 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 6/18/24 16:12 | 1/26/24 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Schuler Jack W | IL | T |  | P.d | 0 | 0.00 | 0 | 29 | 2 | 1,912 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 6/3/24 17:30 | 5/31/24 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sandford Nicole | TX | DO | CEO | P | 23 | 2.42 | 0 | 9 | 16 | 71 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 4/17/24 12:04 | 4/17/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Jones Douglas Edward | MI | O | COO | P | 124 | 12.36 | 0 | 10 | 28 | 46 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 4/15/24 19:21 | 4/11/24 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Broadwood Partners, L.P. | NY | T |  | P.d | 7,058 | 2.92 | 0 | 2,420 | 33 | 9,858 | M |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 4/15/24 06:04 | 4/11/24 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Riggs Josh | CA | DO | CEO,P | P | 10 | 2.95 | 0 | 3 | 999% | 4 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 4/15/24 06:02 | 4/11/24 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Arno Andrew | CA | D |  | P | 100 | 2.95 | 0 | 34 | 67 | 85 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 4/11/24 11:40 | 4/11/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Borel James C | DE | D |  | P | 98 | 13.06 | 0 | 8 | 54 | 21 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 4/10/24 16:18 | 4/10/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Naemura David H. | MI | O | CFO | P | 156 | 12.51 | 0 | 13 | 71 | 30 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 4/10/24 14:25 | 4/10/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | MI | O | CEO | P | 284 | 12.36 | 0 | 23 | 18 | 152 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 3/8/24 11:24 | 3/6/24 | CATX | Perspective Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lantheus Alpha Therapy, LLC | MA | T |  | P | 57,409 | 0.9500 | 0 | 60,431 | 107 | 116,773 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 3/6/24 16:49 | 3/4/24 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Stewart Richard Alistair | WA | DO | Exec CB | P.d | 46 | 4.59 | 0 | 10 | 35 | 39 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 3/6/24 16:43 | 3/4/24 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bencich John | WA | DO | CEO | P.d | 46 | 4.59 | 0 | 10 | 15 | 77 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 2/27/24 16:21 | 8/15/22 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Grossman Paul David | CA | D |  | P.m | 50 | 5.37 | 0 | 9 | New | 9 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 2/26/24 18:48 | 2/23/24 | QDEL | Quidelortho Corp |  | Health | Diagn | In Vitro & In Vivo Diagnostic | Busky Joseph M | CA | O | CFO | P | 100 | 46.36 | 0 | 2 | 54 | 6 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 1/30/24 20:31 | 1/26/24 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sandford Nicole | TX | DO | P,CEO | P.d | 0 | 0.00 | 0 | 2 | 4 | 61 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 12/19/23 10:59 | 12/18/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Butera Salvatore Thomas | NV | O | CEO - Vo | P | 8 | 0.8300 | 0 | 10 | 4 | 278 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 12/18/23 09:38 | 12/15/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Butera Salvatore Thomas | NV | O | CEO - Vo | P | 8 | 0.7700 | 0 | 10 | 4 | 268 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 12/14/23 09:11 | 12/13/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Rootsaert Rodney Gerard | NV | O | Secretar | P | 6 | 0.6000 | 0 | 10 | 1 | 1,086 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 12/11/23 08:51 | 12/8/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Reynolds Cameron John | NV | DO | P,CEO | P | 7 | 0.6700 | 0 | 10 | 0 | 2,746 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 12/6/23 17:21 | 12/6/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sandford Nicole | TX | DO | P,CEO | P | 17 | 3.36 | 0 | 5 | 9 | 59 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 12/1/23 17:44 | 11/30/23 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Gelhaus Ken | CA | O | Chief Co | P | 6 | 1.73 | 0 | 4 | 19 | 23 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 11/28/23 09:39 | 11/27/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | NV | D |  | P | 15 | 0.7700 | 0 | 20 | 1 | 2,601 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 11/28/23 09:39 | 11/27/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Futcher Edward | NV | D |  | P | 7 | 0.8000 | 0 | 9 | 2 | 428 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 11/27/23 10:28 | 11/24/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | NV | D |  | P | 8 | 0.7600 | 0 | 10 | 0 | 2,581 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 11/24/23 11:06 | 11/22/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | NV | D |  | P | 14 | 0.7100 | 0 | 20 | 1 | 2,571 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 11/17/23 10:01 | 11/16/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Butera Salvatore Thomas | NV | O | CEO - Vo | P | 8 | 0.8100 | 0 | 10 | 4 | 258 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 11/3/23 13:59 | 11/3/23 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Boehm William T |  | D |  | P | 32 | 16.06 | 0 | 2 | 8 | 27 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/26/23 08:01 | 10/25/23 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Jones Douglas Edward | MI | O | COO | P | 152 | 15.17 | 0 | 10 | 38 | 36 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/12/23 16:01 | 10/12/23 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Tobin James P | MI | D |  | P | 46 | 15.19 | 0 | 3 | 17 | 20 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/11/23 16:21 | 10/11/23 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Naemura David H. | MI | O | CFO | P | 150 | 15.03 | 0 | 10 | New | 10 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 9/21/23 20:58 | 9/19/23 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Telegraph Hill Partners Iv, L.P. | CA | T |  | P | 15,000 | 1.85 | 0 | 8,108 | 46 | 25,621 | M |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 9/21/23 17:04 | 9/19/23 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Terrill Damon | CA | O | GC,CCO | P | 50 | 1.85 | 0 | 27 | 193 | 41 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 9/21/23 17:04 | 9/19/23 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Mackowski J Matthew | CA | D |  | P | 1,500 | 1.85 | 0 | 811 | 999% | 821 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 9/21/23 17:03 | 9/19/23 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lowell Matthew | CA | O | CFO | P | 100 | 1.85 | 0 | 54 | 159 | 88 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 9/21/23 17:03 | 9/19/23 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Gunstream Stephen | CA | DO | P,CEO | P | 100 | 1.85 | 0 | 54 | 50 | 163 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 9/19/23 16:05 | 8/31/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Henshall Mickie | NV | D |  | P | 5 | 1.25 | 0 | 4 | 25 | 19 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 9/12/23 18:37 | 9/8/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hombeck Torsten | TX | O | CFO | P | 10 | 4.30 | 0 | 2 | 298 | 3 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 9/8/23 12:18 | 8/25/23 | CDIO | Cardio Diagnostics Holdings, Inc. |  | Health | Diagn | In Vitro & In Vivo Diagnostic | Dogan Meeshanthini | IL | DOT | CEO | P.m | 10 | 0.5460 | 0 | 18 | 17 | 128 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 9/8/23 12:12 | 8/25/23 | CDIO | Cardio Diagnostics Holdings, Inc. |  | Health | Diagn | In Vitro & In Vivo Diagnostic | Dogan Timur | IL | O | CTO | P.m | 10 | 0.5460 | 0 | 18 | 17 | 128 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 9/6/23 10:01 | 9/5/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Barnes Phillip | NV | D |  | P | 7 | 1.30 | 0 | 5 | 25 | 25 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 9/5/23 16:14 | 8/24/23 | CDIO | Cardio Diagnostics Holdings, Inc. |  | Health | Diagn | In Vitro & In Vivo Diagnostic | Philibert Robert | IL | DOT | Chief Me | P.m | 20 | 0.5999 | 0 | 34 | 1 | 3,282 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 9/1/23 09:41 | 8/31/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Faulkes Martin Charles | NV | D |  | P | 12 | 1.28 | 0 | 10 | 0 | 2,030 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 8/31/23 09:35 | 8/29/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Micallef Jacob Vincent | NV | O | Chief Sc | P.m | 25 | 1.25 | 0 | 20 | 6 | 328 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 8/28/23 10:07 | 8/25/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Micallef Jacob Vincent | NV | O | Chief Sc | P | 25 | 1.24 | 0 | 20 | 7 | 308 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 8/25/23 11:49 | 8/24/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Kway Jasmine | NV | O | CEO - Si | P | 6 | 1.20 | 0 | 5 | 6 | 87 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 8/25/23 11:49 | 8/24/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Futcher Edward | NV | D |  | P | 6 | 1.22 | 0 | 5 | 1 | 419 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 8/24/23 17:58 | 8/24/23 | MYMD | Mymd Pharmaceuticals, Inc. | NJ | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivard Paul | MD | O | GC | P | 167 | 1.11 | 0 | 150 | 60 | 400 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 8/24/23 12:00 | 8/24/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Michel Gaetan | NV | O | COO | P | 6 | 1.23 | 0 | 5 | 2 | 213 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 8/18/23 16:21 | 8/17/23 | MYMD | Mymd Pharmaceuticals, Inc. | NJ | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivard Paul | MD | O | GC | P | 28 | 1.12 | 0 | 25 | 11 | 250 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 8/17/23 09:40 | 8/16/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Butera Salvatore Thomas | NV | O | CEO - Vo | P | 10 | 1.21 | 0 | 8 | 3 | 254 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 8/16/23 12:28 | 8/16/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Reynolds Cameron John | NV | DO | P,CEO | P | 12 | 1.22 | 0 | 10 | 0 | 2,536 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 7/26/23 19:28 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Fralick Celeste Rachelle | TX | D |  | P | 3 | 3.98 | 0 | 1 | 7 | 12 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 7/26/23 16:28 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Vos Ellen O'Connor | CT | D |  | P | 15 | 3.98 | 0 | 4 | 13 | 33 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 7/25/23 17:39 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Schuler Jack W | IL | T |  | P | 500 | 2.75 | 0 | 182 | 11 | 1,884 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 7/25/23 17:20 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cavanaugh Stefanie L. | TX | D |  | P | 25 | 3.98 | 0 | 6 | 22 | 35 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 7/25/23 17:16 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sandford Nicole | TX | DO | P,CEO | P | 50 | 3.98 | 0 | 13 | 10 | 135 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 7/25/23 17:11 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Phan Ryan Thinh | TX | O | CSO,COO | P | 2 | 3.98 | 0 | 1 | 19 | 4 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 7/25/23 17:03 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Parnell Winfred | TX | D |  | P | 25 | 3.98 | 0 | 6 | 25 | 32 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 7/25/23 16:58 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Merchant Minh Hoang | TX | O | GC,secre | P | 3 | 3.98 | 0 | 1 | 18 | 5 | M |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 7/24/23 18:58 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Jordan Veronica Gh | TX | D |  | P | 15 | 3.98 | 0 | 4 | 12 | 35 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 7/24/23 18:53 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hombeck Torsten | TX | O | CFO | P | 3 | 3.98 | 0 | 1 | New | 1 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 7/24/23 18:49 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Herchuk Jannie Prestridge | TX | D |  | P | 35 | 3.98 | 0 | 9 | 58 | 24 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 6/26/23 10:27 | 4/25/23 | NYMX | Nymox Pharmaceutical Corp |  | Health | Diagn | In Vitro & In Vivo Diagnostic | Robinson James George | MD | DT |  | P.am | 37 | 0.4600 | 0 | 80 | 2 | 4,782 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 6/15/23 20:13 | 6/14/23 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Kingsley Alfred D | NY | D |  | P | 6 | 0.2149 | 0 | 30 | 6 | 563 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 6/6/23 10:14 | 6/2/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Butera Salvatore Thomas | NV | O | CEO - Vo | P | 16 | 1.59 | 0 | 10 | 5 | 217 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 6/1/23 17:42 | 5/30/23 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bencich John | WA | DO | CEO | P | 28 | 5.50 | 0 | 5 | 8 | 67 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 5/31/23 17:16 | 5/26/23 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Davis Ted | CA | DT |  | P | 6 | 3.22 | 0 | 2 | 0 | 3,576 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 5/31/23 17:16 | 5/26/23 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Davis Irene | CA | DT |  | P | 6 | 3.22 | 0 | 2 | 0 | 3,576 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 5/26/23 12:23 | 5/24/23 | BMRA | Biomerica Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Irani Zackary S. | CA | DO | CEO | P.m | 1 | 1.59 | 0 | 1 | 0 | 1,021 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 5/18/23 16:09 | 4/25/23 | NYMX | Nymox Pharmaceutical Corp |  | Health | Diagn | In Vitro & In Vivo Diagnostic | Robinson James George | MD | DT |  | P.a | 18 | 0.4500 | 0 | 40 | 1 | 4,742 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 5/16/23 19:07 | 5/12/23 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Gunstream Stephen | CA | DO | P,CEO | P | 8 | 1.67 | 0 | 5 | 4 | 109 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 5/16/23 19:07 | 5/12/23 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Gelhaus Ken | CA | O | Chief Co | P | 7 | 1.67 | 0 | 4 | 25 | 19 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 5/16/23 19:07 | 5/12/23 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hood Lisa | CA | O | Chief Pe | P | 5 | 1.67 | 0 | 3 | 7 | 48 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 5/12/23 16:39 | 5/12/23 | BMRA | Biomerica Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Irani Zackary S. | CA | DO | CEO | P | 2 | 1.17 | 0 | 2 | 0 | 1,020 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 5/12/23 16:06 | 5/10/23 | BMRA | Biomerica Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Irani Zackary S. | CA | DO | CEO | P | 1 | 1.27 | 0 | 1 | 0 | 1,018 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 5/10/23 17:28 | 5/9/23 | BMRA | Biomerica Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Irani Zackary S. | CA | DO | CEO | P | 0 | 1.39 | 0 | 0 | 0 | 1,018 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 5/5/23 14:38 | 5/4/23 | BMRA | Biomerica Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Irani Zackary S. | CA | DO | CEO | P | 1 | 1.36 | 0 | 1 | 0 | 1,017 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 5/1/23 09:15 | 4/27/23 | BMRA | Biomerica Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Irani Zackary S. | CA | DO | CEO | P.m | 6 | 1.32 | 0 | 4 | 0 | 1,017 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 4/27/23 08:55 | 4/26/23 | BMRA | Biomerica Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Irani Zackary S. | CA | DO | CEO | P | 9 | 1.26 | 0 | 7 | 1 | 1,013 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 4/7/23 17:12 | 4/5/23 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Pura Vida Investments, LLC | NY | T |  | P | 200 | 0.3017 | 0 | 663 | 5 | 14,829 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 4/5/23 21:35 | 4/3/23 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Broadwood Partners, L.P. | NY | T |  | P.d | 8,094 | 0.3017 | 0 | 26,828 | 36 | 100,366 | M |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 2/23/23 15:54 | 2/22/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | NV | D |  | P | 410 | 1.75 | 0 | 234 | 12 | 2,235 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 1/31/23 10:06 | 1/27/23 | BMRA | Biomerica Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Barbieri Allen | CA | DO | Exec Vic | P | 5 | 2.94 | 0 | 2 | 2 | 101 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 1/30/23 11:36 | 1/26/23 | BMRA | Biomerica Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Coste Catherine | CA | DH | Audit Co | P | 6 | 2.96 | 0 | 2 | 5 | 44 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  |